China
China’s healthcare index sinks 7.1% as investors pivot to tech AI
China’s healthcare index sinks 7.1% as investors pivot to tech AI
The sector’s stocks lag as AI inflows reshaped sector allocation patterns.
China's licensing boom reshapes global pharma power
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.
Why China's pharma market is now a consumer game
Stakeholders must understand this moment, as it signifies a fundamental shift in the industry.
China’s pharma growth shifts from drugs to high-tech manufacturing
However, there is still a lot of pressure in pharmaceutical manufacturing.
Raffles Medical, Chongqing Hospital to form new collaboration model
A key partnership area includes the development of a medical consortium.
Healthcare improvements drive China’s oxygenators market
The country is expected to maintain a 50% market share in APAC through 2025.
Read Here
Advertise
Sign Up
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention
How the healthcare ecosystem is responding to change the trajectory of myopia